Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 11Neoplasms 5Stomach Neoplasms 2Small Cell Lung Carcinoma 2Ovarian Neoplasms 2Metastatic Pancreatic Adenocarcinoma 2Head and Neck Neoplasms 2Glioma 2Colorectal Neoplasms 2Biliary Tract Neoplasms 2Weight Loss 1Triple Negative Breast Neoplasms 1Solid Tumor 1Refractory Solid Tumors 1Pseudomyxoma Peritonei 1Pancreatic cancer, adult 1Pancreatic Diseases 1Oligodendroglioma 1Neoplasms, Cystic, Mucinous, and Serous 1Metastatic Adenocarcinoma of the Pancreas 1Mesothelioma 1Malignant Solid Neoplasm 1Locally Advanced Rectal Cancer (LARC) 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Gliosarcoma 1Glioblastoma 1Fallopian Tube Neoplasms 1Endocrine Gland Neoplasms 1Disease 1Digestive System Neoplasms 1

Interventions

Gemcitabine 7Leucovorin 6Irinotecan 6Fluorouracil 6130-nm albumin-bound paclitaxel 6Albumin-Bound Paclitaxel 5napabucasin 4Capecitabine 4Paclitaxel 3Oxaliplatin 3Ocoxin 3Bevacizumab 3pembrolizumab 2entinostat 2Sorafenib 2Imatinib Mesylate 2Everolimus 2Cyclophosphamide 2Cisplatin 2Cetuximab 25,10-methylenetetrahydrofolic acid 2tislelizumab 1spartalizumab 1pralsetinib 1palbociclib 1irinotecan sucrosofate 1halofantrine 1guadecitabine 1fludarabine 1ficlatuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Digestive System Neoplasms × irinotecan sucrosofate × Clear all
NCT02231723 2023-11-18

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

Sumitomo Pharma America, Inc.

Phase 1 Completed
139 enrolled
Gastrointestinal

Pancreatic cancer, adult, Digestive System Neoplasms, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Islet Cell, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡